23andMe Files for Bankruptcy, Urges Customers to Delete Data

23andMe, the genetic testing company, has filed for Chapter 11 bankruptcy, marking a significant downturn for the Silicon Valley firm. The company, known for its ancestry and medical DNA services, announced the filing amidst financial struggles and a data breach that compromised millions of users' genetic information. California Attorney General Rob Bonta issued an urgent consumer alert, advising 23andMe customers to delete their data from the company's servers to protect their privacy.

The bankruptcy filing comes after years of operational challenges and a significant data breach in 2023, which exposed the genetic data of nearly 7 million users. The breach led to a class-action lawsuit and a sharp decline in customer trust. 23andMe's CEO, Anne Wojcicki, stated that the decision to file for bankruptcy was made to restructure the company and focus on core services.

Customers are now faced with the dilemma of whether to delete their genetic data or risk it being sold or misused during the bankruptcy proceedings. The company has provided instructions on how to delete data, but the process is complex, leaving many users uncertain about their next steps.

• 23andMe
• Anne Wojcicki
• California
• Rob Bonta

Related issues news

How do I delete my account on 23andMe?

Click your username, then click 'Settings.' Scroll down to the bottom where it says '23andMe Data' and click 'View.' Scroll down to the bottom of this page, and click 'Permanently Delete Data.'

Did 23andme file bankruptcy?

23andMe, maker of popular DNA test kits, announced Sunday that it has filed for Chapter 11 bankruptcy and is looking for a buyer. Although the company has promised to continue protecting customer data amidst a possible sale, California's attorney general has advised 23andMe users to consider deleting their information.

How to protect 23andme data?

To protect your privacy, consider downloading your data and deleting your account. You can also email 23andME to revoke consent for future research and request that your biological sample be destroyed. Associated Press. 23andMe cuts 40% of its workforce and discontinues therapeutics division.

X talks about this news